Xiaozhong H. Wang
Ueruemqi, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon.
Journal: Hepatology international
Published: July 31, 2025
Noninvasive Detection of Occult yet Significant Liver Pathology in Alanine Aminotransferase-Normal Chronic Hepatitis B: A Multicenter Study.
Journal: The Journal of infectious diseases
Published: June 26, 2025
A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B.
Journal: Hepatology (Baltimore, Md.)
Published: April 03, 2025
Real-world Effectiveness and Tolerability of Interferon-free Direct-acting Antiviral for 15,849 Patients with Chronic Hepatitis C: A Multinational Cohort Study.
Journal: Journal of clinical and translational hepatology
Published: March 07, 2024
Alfosbuvir plus Daclatasvir for Treatment of Chronic Hepatitis C Virus Infection in China.
Journal: Infectious diseases and therapy
Published: July 17, 2023
Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial.
Journal: The American journal of gastroenterology
Published: July 17, 2023
Real-world treatment outcome with protease inhibitor direct-acting antiviral in advanced hepatitis C cirrhosis: a REAL-C study.
Journal: Hepatology international
Published: November 22, 2022
Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China.
Journal: Journal of clinical and translational hepatology
Published: October 26, 2020
Seraprevir and sofosbuvir for treatment of chronic hepatitis C virus infection: A single-arm, open-label, phase 3 trial.
Journal: Journal of gastroenterology and hepatology
Published: October 11, 2020
Screening varices in patients with HBV-related cirrhosis on antiviral therapy: Platelet alone or together with LSM.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: September 02, 2020
High hepatitis C virus cure rates with approved interferon-free direct-acting antivirals among diverse mainland Chinese patients including genotypes 3a and 3b.
Journal: Journal of gastroenterology and hepatology
Published: June 19, 2020
Last Updated: 09/26/2026